Surprised that some of the interest in UCG prompted by Linc's deals have not rubbed off on Cougar's sp. Market seems to have priced the chances of Cougar pulling of a similar deal as zero. Maybe too pessimistic? Not a whole lot of companies around the world with pilot plant experience to compete against, I would have thought. Chances of a Lazarus with a triple bypass recovery cannot be ruled out totally. Something for the patient to consider.
CXY Price at posting:
0.5¢ Sentiment: ST Buy Disclosure: Held